NASDAQ:CSII - Cardiovascular Systems Stock Price, Forecast & News

Cardiovascular Systems' stock was trading at $36.32 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CSII stock has decreased by 6.5% and is now trading at $33.96. View which stocks have been mosted impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Cardiovascular Systems.

Cardiovascular Systems is scheduled to release its next quarterly earnings announcement on Wednesday, May 6th 2020. View our earnings forecast for Cardiovascular Systems.

Cardiovascular Systems Inc (NASDAQ:CSII) announced its earnings results on Wednesday, February, 5th. The medical device company reported ($0.10) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.03) by $0.07. The medical device company had revenue of $68.33 million for the quarter, compared to analysts' expectations of $67.90 million. Cardiovascular Systems had a negative net margin of 2.66% and a negative return on equity of 4.90%. View Cardiovascular Systems' earnings history.

Cardiovascular Systems updated its FY 2020 After-Hours earnings guidance on Wednesday, February, 5th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $280-283 million, compared to the consensus revenue estimate of $280.7 million.

5 equities research analysts have issued 1-year target prices for Cardiovascular Systems' shares. Their forecasts range from $42.00 to $60.00. On average, they anticipate Cardiovascular Systems' share price to reach $51.25 in the next year. This suggests a possible upside of 50.9% from the stock's current price. View analysts' price targets for Cardiovascular Systems.

News stories about CSII stock have trended positive recently, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Cardiovascular Systems earned a media sentiment score of 2.1 on InfoTrie's scale. They also gave news articles about the medical device company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days. View the latest news aboutCardiovascular Systems.

Cardiovascular Systems saw a decline in short interest during the month of March. As of March 13th, there was short interest totaling 1,868,000 shares, a decline of 11.9% from the February 27th total of 2,120,000 shares. Based on an average daily trading volume, of 328,100 shares, the short-interest ratio is presently 5.7 days. Currently, 5.5% of the company's stock are sold short. View Cardiovascular Systems' Current Options Chain.

Some companies that are related to Cardiovascular Systems include Abbott Laboratories (ABT), Medtronic (MDT), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Stryker (SYK), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Steris (STE), Insulet (PODD) and Masimo (MASI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include AbbVie (ABBV), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Netflix (NFLX), Twitter (TWTR), Verizon Communications (VZ), Xcel Energy (XEL), Activision Blizzard (ATVI), Ionis Pharmaceuticals (IONS) and Paypal (PYPL).

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

Cardiovascular Systems' stock is owned by a number of institutional and retail investors. Top institutional investors include Champlain Investment Partners LLC (6.80%), Renaissance Technologies LLC (4.77%), State Street Corp (3.41%), New York State Common Retirement Fund (2.17%), Geode Capital Management LLC (1.58%) and Janus Henderson Group PLC (1.53%). Company insiders that own Cardiovascular Systems stock include Alexander Rosenstein, Jeffrey S Points, Martha Goldberg Aronson, Sandra Sedo and Scott R Ward. View institutional ownership trends for Cardiovascular Systems.

CSII stock was sold by a variety of institutional investors in the last quarter, including Partner Fund Management L.P., Falcon Point Capital LLC, Prudential Financial Inc., Russell Investments Group Ltd., PNC Financial Services Group Inc., Bank of New York Mellon Corp, Arizona State Retirement System, and Sei Investments Co.. Company insiders that have sold Cardiovascular Systems company stock in the last year include Alexander Rosenstein, and Sandra Sedo. View insider buying and selling activity for Cardiovascular Systems.

CSII stock was purchased by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Champlain Investment Partners LLC, Norges Bank, Sectoral Asset Management Inc, Renaissance Technologies LLC, Madison Asset Management LLC, Bank of Montreal Can, and Jacobs Levy Equity Management Inc.. Company insiders that have bought Cardiovascular Systems stock in the last two years include Martha Goldberg Aronson, and Scott R Ward. View insider buying and selling activity for Cardiovascular Systems.

Shares of CSII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CSII stock can currently be purchased for approximately $33.96.

Cardiovascular Systems has a market capitalization of $1.20 billion and generates $248.02 million in revenue each year. The medical device company earns $-250,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis. Cardiovascular Systems employs 652 workers across the globe. View additional information about Cardiovascular Systems.

The official website for Cardiovascular Systems is http://www.csi360.com/.

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The medical device company can be reached via phone at 651-259-1600 or via email at [email protected]